Long-acting anticholinesterases for myasthenia gravis: Synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine

Qian Sheng Yu, Harold W. Holloway, Weiming Luo, Debomoy K. Lahiri, Arnold Brossi, Nigel H. Greig

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The N-monophenylcarbamate analogues of neostigmine methyl sulfate (6) and pyridostigmine bromide (8) together with their precursors (5), (7), and the N(1)-methylammonium analogues of (-)-phenserine (12), (-)-tolserine (14), (-)-cymserine (16) and (-)-phenethylcymserine (18) were synthesized to produce long-acting peripheral inhibitors of acetylcholinesterase or butyrylcholinesterase. Evaluation of their cholinesterase inhibition against human enzyme ex vivo demonstrated that, whereas compounds 5-8 possessed only marginal activity, 12, 14, 16 and 18 proved to be potent anticholinesterases. An extended duration of cholinesterase inhibition was determined in rodent, making them of potential interest as long-acting agents for myasthenia gravis.

Original languageEnglish (US)
Pages (from-to)4687-4693
Number of pages7
JournalBioorganic and Medicinal Chemistry
Volume18
Issue number13
DOIs
StatePublished - Jun 2 2010

Fingerprint

Phenylcarbamates
Pyridostigmine Bromide
Neostigmine
Physostigmine
Myasthenia Gravis
Cholinesterase Inhibitors
Cholinesterases
Butyrylcholinesterase
Rodentia
Enzymes

Keywords

  • (-)-Cymserine
  • (-)-Phenserine
  • Congenital myasthenic syndromes
  • Myasthenia gravis
  • N-Phenylcarbamate analogues of (-)-physostigmine
  • Neostigmine
  • Pyridostigmine

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Long-acting anticholinesterases for myasthenia gravis : Synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. / Yu, Qian Sheng; Holloway, Harold W.; Luo, Weiming; Lahiri, Debomoy K.; Brossi, Arnold; Greig, Nigel H.

In: Bioorganic and Medicinal Chemistry, Vol. 18, No. 13, 02.06.2010, p. 4687-4693.

Research output: Contribution to journalArticle

@article{c7d582155aaf49e6824ce5731a731b1c,
title = "Long-acting anticholinesterases for myasthenia gravis: Synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine",
abstract = "The N-monophenylcarbamate analogues of neostigmine methyl sulfate (6) and pyridostigmine bromide (8) together with their precursors (5), (7), and the N(1)-methylammonium analogues of (-)-phenserine (12), (-)-tolserine (14), (-)-cymserine (16) and (-)-phenethylcymserine (18) were synthesized to produce long-acting peripheral inhibitors of acetylcholinesterase or butyrylcholinesterase. Evaluation of their cholinesterase inhibition against human enzyme ex vivo demonstrated that, whereas compounds 5-8 possessed only marginal activity, 12, 14, 16 and 18 proved to be potent anticholinesterases. An extended duration of cholinesterase inhibition was determined in rodent, making them of potential interest as long-acting agents for myasthenia gravis.",
keywords = "(-)-Cymserine, (-)-Phenserine, Congenital myasthenic syndromes, Myasthenia gravis, N-Phenylcarbamate analogues of (-)-physostigmine, Neostigmine, Pyridostigmine",
author = "Yu, {Qian Sheng} and Holloway, {Harold W.} and Weiming Luo and Lahiri, {Debomoy K.} and Arnold Brossi and Greig, {Nigel H.}",
year = "2010",
month = "6",
day = "2",
doi = "10.1016/j.bmc.2010.05.022",
language = "English (US)",
volume = "18",
pages = "4687--4693",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "13",

}

TY - JOUR

T1 - Long-acting anticholinesterases for myasthenia gravis

T2 - Synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine

AU - Yu, Qian Sheng

AU - Holloway, Harold W.

AU - Luo, Weiming

AU - Lahiri, Debomoy K.

AU - Brossi, Arnold

AU - Greig, Nigel H.

PY - 2010/6/2

Y1 - 2010/6/2

N2 - The N-monophenylcarbamate analogues of neostigmine methyl sulfate (6) and pyridostigmine bromide (8) together with their precursors (5), (7), and the N(1)-methylammonium analogues of (-)-phenserine (12), (-)-tolserine (14), (-)-cymserine (16) and (-)-phenethylcymserine (18) were synthesized to produce long-acting peripheral inhibitors of acetylcholinesterase or butyrylcholinesterase. Evaluation of their cholinesterase inhibition against human enzyme ex vivo demonstrated that, whereas compounds 5-8 possessed only marginal activity, 12, 14, 16 and 18 proved to be potent anticholinesterases. An extended duration of cholinesterase inhibition was determined in rodent, making them of potential interest as long-acting agents for myasthenia gravis.

AB - The N-monophenylcarbamate analogues of neostigmine methyl sulfate (6) and pyridostigmine bromide (8) together with their precursors (5), (7), and the N(1)-methylammonium analogues of (-)-phenserine (12), (-)-tolserine (14), (-)-cymserine (16) and (-)-phenethylcymserine (18) were synthesized to produce long-acting peripheral inhibitors of acetylcholinesterase or butyrylcholinesterase. Evaluation of their cholinesterase inhibition against human enzyme ex vivo demonstrated that, whereas compounds 5-8 possessed only marginal activity, 12, 14, 16 and 18 proved to be potent anticholinesterases. An extended duration of cholinesterase inhibition was determined in rodent, making them of potential interest as long-acting agents for myasthenia gravis.

KW - (-)-Cymserine

KW - (-)-Phenserine

KW - Congenital myasthenic syndromes

KW - Myasthenia gravis

KW - N-Phenylcarbamate analogues of (-)-physostigmine

KW - Neostigmine

KW - Pyridostigmine

UR - http://www.scopus.com/inward/record.url?scp=77954218797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954218797&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2010.05.022

DO - 10.1016/j.bmc.2010.05.022

M3 - Article

C2 - 20627738

AN - SCOPUS:77954218797

VL - 18

SP - 4687

EP - 4693

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 13

ER -